Protesters gather outside court as justices set to hear arguments in first major abortion case since Roe v Wade was overturned
It’s not just access to medication abortion that could be upended by a supreme court ruling tightening access to mifepristone. As the Guardian’s
Jessica Glenza
reports, the conservative challengers to the drug have targeted decisions made by the US Food and Drug Administration (FDA) to make it easier to prescribe.
But if the supreme court agrees with their complaint, it opens up the possibility of a wave of challenges to other medications that treat a range of issues. Doctors and pharmaceutical companies have become so concerned about the case that they’ve filed briefs defending the FDA against the conservative challenge.
A supreme court case about one little pill – mifepristone – has the medical and pharmaceutical world on edge. The pill, at the heart of a case that will be argued on Tuesday, is part of a two-drug regimen used to treat miscarriage and end early pregnancies.
Despite a more than 20-year track record of safe real-world use, backed up by more than
100 peer-reviewed studies
, a group of anti-abortion doctors is seeking to roll back US Food and Drug Administration (FDA) decisions that changed and relaxed some prescribing rules.
Joe Biden
has been briefed on the collapse of the Francis Scott Key Bridge in Baltimore. We
have a live blog
covering the latest news on the disaster, and you can find it here.
Is the GOP surrendering
in their push to impeach Biden?
Reports
have emerged that the Republican architect of the attempt to bring charges against the president now says he’ll settle for a criminal referral to the justice department.
The White House
press briefing will take place on Air Force One as Biden heads to campaign in North Carolina, sometime after 1pm.
Continue reading...